Institute for Research in Biomedicine (IRB Barcelona)

Medical research

Biosynthetic capacity: The key to switch-off cancer stem cells

Tumours are not a uniform mass of cells. Colon cancers bear differentiated-like cells, similar to the functional cells of the intestinal wall, and pluripotent cells—the so-called tumour stem cells. The latter fuel tumour ...

Oncology & Cancer

Inhibition of p38 reduces the growth of lung tumors

One of the biggest challenges faced by biomedicine is the development of more selective and efficient cancer treatments. In 2018, 1.7 million people died from lung cancer worldwide, a number equivalent to the population of ...

Oncology & Cancer

Genetic alterations caused by cancer therapies identified

Living implies change. This is what happens to the cells of our bodies as we grow older: They accumulate genetic alterations, most of which are harmless. However, in some specific cases, these mutations can affect certain ...

Oncology & Cancer

Formation of new blood vessels in tumors regulated by p38 protein

A study performed at the Institute for Research in Biomedicine(IRB Barcelona) and published in the journal Nature Communications demonstrates that inhibition of the p38 protein boosts the formation of blood vessels in human ...

page 4 from 11